Ghana, a key player in Africa’s immunization landscape, faces a significant challenge with the suspension of United States Agency for International Development (USAID) funding programs. These programs, totaling approximately $156 million, support crucial initiatives including malaria prevention, maternal and child health, nutrition, and HIV services. The disruption has sparked concerns about the stability of routine immunization systems, particularly in remote communities like Akuapim North.
Specifically, a recent study examining donor withdrawal in northern Ghana revealed that 75% of districts surveyed reported vaccine delays or irregular supplies. This issue is compounded by constraints affecting cold-chain equipment, delivery kits, and transport fuel – all vital components of maintaining the integrity of the immunization process. Nana Owusu Ensaw, municipal director of health for Akuapim North, expressed concern that the funding shock should be redirected towards rethinking healthcare financing in Ghana. The Ghana Medical Trust Fund, or MahamaCares, is already expanding access to specialized care, but this shift doesn’t fully address the underlying funding gap.
This situation is further amplified by the recent report from Al Jazeera Africa detailing a potential $78.2 million shortfall across affected programs. The USAID cut, coupled with the ongoing challenges of remote community access, threatens to undermine the gains made in reducing child mortality rates. Ghana’s Eastern and Oti regions, particularly the Oti Region, experience a concerning 2025 rate of 85.3% coverage for routine immunizations, compared to the national target of 62.1%. The concern is exacerbated by the potential for these funding pressures to erode established outreach networks and ultimately impact the health of vulnerable children.
John Yabani, the medical director of Banahene Specialist Hospital, acknowledged the need to reassess healthcare financing, emphasizing that private sector involvement is crucial. The private sector is increasingly positioned to fill the gap, offering complementary services and potentially contributing to the economic growth of Ghana. However, this transition requires more than simply finding alternative funding sources, as health workers still face significant logistical hurdles – including extensive travel to remote communities to trace missed doses, maintain cold chains, and provide outreach services.
Furthermore, the suspension of USAID funding is not merely a setback; it represents a critical juncture. The loss of Gavi support, a pivotal initiative for strengthening immunization programs across the African continent, introduces a complex challenge. Gavi is expected to take full responsibility for financing immunization programs from 2030, placing Ghana under pressure from two primary pressures: the immediate disruption caused by the withdrawal of US funding and the longer-term need to significantly increase domestic contributions to immunization costs.
Despite these challenges, Ghana is actively pursuing strategies to mitigate these risks. The government has removed the cap on funding for the National Health Insurance Scheme, and efforts are underway to develop local vaccine manufacturing capacity. However, this transition will take time, and the situation underscores a difficult balancing act – between prioritizing the immediate needs of children and the long-term sustainability of Ghana’s health system.
Experts warn that without a concerted effort, Ghana risks eroding the gains made in reducing child mortality rates, particularly in vulnerable communities, and further widening existing health disparities.
Watch Related Video
Source: Al Jazeera Africa
